First Amendment to Exclusive Patent License Agreement, dated October 20, 2014, between the Registrant and Regents of the University of Minnesota
Exhibit 10.10
FIRST AMENDMENT
TO EXCLUSIVE PATENT LICENSE AGREEMENT
THIS FIRST AMENDMENT TO EXCLUSIVE PATENT LICENSE AGREEMENT (the First Amendment) is made and entered effective as of the date of the last signature (the First Amendment Effective Date), by and between Regents of the University of Minnesota (the University), a Minnesota constitutional corporation under the laws of the state of Minnesota, having a place of business at 200 Oak Street, SE, Suite 280, Minneapolis, Minnesota 55455, and Acutus Medical, Inc., corporation under the laws of the State of Delaware, having a place of business at 10840 Thornmint Road, Suite 100, San Diego, CA 92127 (the Licensee) each a Party and collectively, the Parties).
BACKGROUND
The Parties entered into an Exclusive Patent License Agreement on on April 21, 2014 (the EPLA). The University and Licensee have now jointly developed an additional Subject Invention and the parties now wish to amend the EPLA to include that invention.
NOW, THEREFORE, THE PARTIES AGREE THAT:
1. The parties hereby amend the EPLA as of the First Amendment Effective Date to add the following Licensed Patent Application to Section 5.2:
Application No. | Country | Filing Date | Title | |||
61/905,451 | U.S. | 11/18/2013 | System and Method for Temporal Sparse Promoting Imaging of Cardiac Electrical Activation |
2. General. Except as amended, deleted, or otherwise modified by this First Amendment, the terms of the EPLA shall remain in full force and effect.
IN WITNESS WHEREOF, acting through their respective duly authorized representatives, the University and the Licensee have duly executed, delivered and entered into this First Amendment as of the Amendment Effective Date.
[Signature Page Follows]
Regents of the University of Minnesota | Acutus Medical, Inc. | |||||||
By: | /s/ Richard Huebsch | By: | /s/ Randy Werneth | |||||
Name: | Richard Huebsch | Name: | Randy Werneth | |||||
Title: | Assoc. Dir., OTC | Title: | President and CEO | |||||
Date: | 10-15-14 | Date: | 10/20/14 |